Crown Bioscience Announces Four New Preclinical NASH Models in Development

SAN DIEGO, Jun. 12 (Korea Bizwire) — Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, today announced four new preclinical translational NASH models in development. NASH is a degenerative liver disease that affects up to 12 percent of the adult population [...]